Objectives: Our aim is investigating the predictive potential of these available and convenient laboratory dates in stage IV colorectal cancer (CRC) patients. Methods: We identified the cases of 114 consecutive patients who underwent the surgery at our Hospital between January 2006 and December 2012 by using the multivariate analysis, the Cox proportional-hazard regression model. Results: Multivariate analysis for the predictors of survival showed metastatic lesion resection [hazard ratio (HR) = 3.2, 95% confidence interval (CI) 1.6 - 6.6; p = 0.007] and only primary lesion resection (HR = 1.9, 95% CI 1.1 - 4.0; p = 0.045) remained independently significant prognostic factors. Therefore, we divided in 3 groups, 1) metastatic lesion resection group with primary lesion resection (n = 52 in the Met/Prim lesion group), 2) primary lesion resection without metastatic lesion resection (n = 38 in the Primary lesion group) and 3) palliative operation (n = 24 in the Palliative group). Age was the only independent risk factor in the Met/Prim lesion group. In the Primary lesion group, Neutrophil lymphocyte ratio (NLR) > 5, elevated Alanine aminotransferase and patients without chemotherapy were correlated with poor survival. In the Palliative group, NLR > 5 and patients who could not be treated with chemotherapy remained independent predictors of worse survival. Conclusions: NLR is not only simple and convenient for classification of patients, but also one of the important predictors of mortality for stage IV incurable CRC patients.
Law, W.L., Fan, J.K., Poon, J.T., Choi, H. and Lo, O.S. (2008) Laparoscopic Bowel Resection in the Setting of Metastatic Colorectal Cancer. Annals of Surgical Oncology, 15, 1424-1428. https://doi.org/10.1245/s10434-008-9820-6
Huh, J.W., Lee, J.H. and Kim, H.R. (2014) Pretreatment Expression of 13 Molecular Markers as a Predictor of Tumor Responses after Neoadjuvant Chemoradiation in Rectal Cancer. Annals of Surgery, 259, 508-515. https://doi.org/10.1097/SLA.0b013e31829b3916
Lee, W.S., Baek, J.H., You, D.H. and Nam, M.J. (2013) Prognostic Value of Circulating Cytokines for Stage III Colon Cancer. Journal of Surgical Research, 182, 49-54. https://doi.org/10.1016/j.jss.2012.08.051
Galizia, G., Orditura, M., Romano, C., Lieto, E., Castellano, P., et al. (2002) Prognostic Significance of Circulating IL-10 and IL-6 Serum Levels in Colon Cancer Patients Undergoing Surgery. Clinical Immunology, 102, 169-178. https://doi.org/10.1006/clim.2001.5163
Kwon, K.A., Kim, S.H., Oh, S.Y., Lee, S., Han, J.Y., et al. (2010) Clinical Significance of Preoperative Serum Vascular Endothelial Growth Factor, Interleukin-6, and C-Reactive Protein Level in Colorectal Cancer. BMC Cancer, 10, 203. https://doi.org/10.1186/1471-2407-10-203
Sideris, M. and Papagrigoriadis, S. (2014) Molecular Biomarkers and Classification Models in the Evaluation of the Prognosis of Colorectal Cancer. Anticancer Research, 34, 2061-2068.
Chua, W., Charles, K.A., Baracos, V.E. and Clarke, S.J. (2011) Neutrophil/Lymphocyte Ratio Predicts Chemotherapy Outcomes in Patients with Advanced Colorectal Cancer. British Journal of Cancer, 104, 1288-1295. https://doi.org/10.1038/bjc.2011.100
McMillan, D.C., Crozier, J.E., Canna, K., Angerson, W.J. and McArdle, C.S. (2007) Evaluation of an Inflammation-Based Prognostic Score (GPS) in Patients Undergoing Resection for Colon and Rectal Cancer. International Journal of Colorectal Disease, 22, 881-886. https://doi.org/10.1007/s00384-006-0259-6
Inoue, Y., Iwata, T., Okugawa, Y., Kawamoto, A., Hiro, J., et al. (2013) Prognostic Significance of a Systemic Inflammatory Response in Patients Undergoing Multimodality Therapy for Advanced Colorectal Cancer. Oncology, 84, 100-107. https://doi.org/10.1159/000343822
Kishi, Y., Kopetz, S., Chun, Y.S., Palavecino, M., Abdalla, E.K., et al. (2009) Blood Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients with Colorectal Liver Metastases treated with Systemic Chemotherapy. Annals of Surgical Oncology, 16, 614-622. https://doi.org/10.1245/s10434-008-0267-6
Walsh, S.R., Cook, E.J., Goulder, F., Justin, T.A. and Keeling, N.J. (2005) Neutrophil-Lymphocyte Ratio as a Prognostic Factor in Colorectal Cancer. Journal of Surgical Oncology, 91, 181-184. https://doi.org/10.1002/jso.20329
Kaneko, M., Nozawa, H., Sasaki, K., Hongo, K., Hiyoshi, M., et al. (2012) Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Advanced Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy. Oncology, 82, 261-268. https://doi.org/10.1159/000337228
Chiang, S.F., Hung, H.Y., Tang, R., Changchien, C.R., Chen, J.S., et al. (2012) Can Neutrophil-to-Lymphocyte Ratio Predict the Survival of Colorectal Cancer Patients Who Have Received Curative Surgery Electively? International Journal of Colorectal Disease, 27, 1347-1357. https://doi.org/10.1007/s00384-012-1459-x
Hung, H.Y., Chen, J.S., Yeh, C.Y., Changchien, C.R., Tang, R., et al. (2011) Effect of Preoperative Neutrophil-Lymphocyte Ratio on the Surgical Outcomes of Stage II Colon Cancer Patients Who Do Not Receive Adjuvant Chemotherapy. International Journal of Colorectal Disease, 26, 1059-1065. https://doi.org/10.1007/s00384-011-1192-x
Sobin, L.H., Gaspodarowicz, M. and Wittekind, C. (2009) TNM Classification of Malignant Tumours. 7th Edition, Wiley-Blackwell, New York.
Forrest, L.M., McMillan, D.C., McArdle, C.S., Angerson, W.J. and Dunlop, D.J. (2003) Evaluation of Cumulative Prognostic Scores Based on the Systemic Inflammatory Response in Patients with Inoperable Non-Small-Cell Lung Cancer. British Journal of Cancer, 89, 1028-1030. https://doi.org/10.1038/sj.bjc.6601242
Mallappa, S., Sinha, A., Gupta, S. and Chadwick, S.J. (2013) Preoperative Neutrophil to Lymphocyte Ratio > 5 Is a Prognostic Factor for Recurrent Colorectal Cancer. Colorectal Disease, 15, 323-328. https://doi.org/10.1111/codi.12008
Kato, T., Yasui, K., Hirai, T., Kanemitsu, Y., Mori, T., et al. (2003) Therapeutic Results for Hepatic Metastasis of Colorectal Cancer with Special Reference to Effectiveness of Hepatectomy: Analysis of Prognostic Factors for 763 Cases Recorded at 18 Institutions. Diseases of the Colon & Rectum, 46, S22-S31.
Tanoue, Y. (2010) Primary Site Resection Is Superior for Incurable Metastatic Colorectal Cancer. World Journal of Gastroenterology, 16, 3561-3566. https://doi.org/10.3748/wjg.v16.i28.3561
Nordlinger, B., Sorbye, H., Glimelius, B., Poston, G.J., Schlag, P.M., et al. (2013) Perioperative FOLFOX4 Chemotherapy and Surgery versus Surgery Alone for Resectable Liver Metastases from Colorectal Cancer (EORTC 40983): Long-Term Results of a Randomised, Controlled, Phase 3 Trial. The Lancet Oncology, 14, 1208-1215. https://doi.org/10.1016/S1470-2045(13)70447-9
Balkwill, F. and Mantovani, A. (2001) Inflammation and Cancer: Back to Virchow? The Lancet, 357, 539-545. https://doi.org/10.1016/S0140-6736(00)04046-0
Biswas, S.K. and Mantovani, A. (2010) Macrophage Plasticity and Interaction with Lymphocyte Subsets: Cancer as a Paradigm. Nature Immunology, 11, 889-896. https://doi.org/10.1038/ni.1937
Gabrilovich, D.I. and Nagaraj, S. (2009) Myeloid-Derived Suppressor Cells as Regulators of the Immune System. Nature Reviews Immunology, 9, 162-174. https://doi.org/10.1038/nri2506